Cargando…

Preoperative Prognostic Index for Patients with Brain Metastases—A Population-Based Multi-Centre Study

SIMPLE SUMMARY: Metastases to the brain result in serious morbidity and mortality. Surgical resection is a treatment option; however, many patients die within a short time after surgery. It is therefore important to understand which patients may benefit from surgical resection. We have investigated...

Descripción completa

Detalles Bibliográficos
Autores principales: Winther, Rebecca Rootwelt, Skovlund, Eva, Andreassen, Joakim Stray, Arvidsson, Lisa, Halvardson, Jonathan, Solheim, Ole, Bartek, Jiri, Kaasa, Stein, Hjermstad, Marianne Jensen, Vik-Mo, Einar Osland
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296417/
https://www.ncbi.nlm.nih.gov/pubmed/37370784
http://dx.doi.org/10.3390/cancers15123174
_version_ 1785063653677989888
author Winther, Rebecca Rootwelt
Skovlund, Eva
Andreassen, Joakim Stray
Arvidsson, Lisa
Halvardson, Jonathan
Solheim, Ole
Bartek, Jiri
Kaasa, Stein
Hjermstad, Marianne Jensen
Vik-Mo, Einar Osland
author_facet Winther, Rebecca Rootwelt
Skovlund, Eva
Andreassen, Joakim Stray
Arvidsson, Lisa
Halvardson, Jonathan
Solheim, Ole
Bartek, Jiri
Kaasa, Stein
Hjermstad, Marianne Jensen
Vik-Mo, Einar Osland
author_sort Winther, Rebecca Rootwelt
collection PubMed
description SIMPLE SUMMARY: Metastases to the brain result in serious morbidity and mortality. Surgical resection is a treatment option; however, many patients die within a short time after surgery. It is therefore important to understand which patients may benefit from surgical resection. We have investigated prognostic factors for survival after surgery for brain metastases. We identified eight factors that significantly predicted survival in these patients and created a preoperative prognostic index to estimate survival and to guide clinical decision-making in evaluating surgery as a treatment for brain metastases. We tested our findings on patients who underwent the same treatment at two other large hospitals in Norway and Sweden, and our findings were valid. This is to our knowledge the first such index to support decision-making in this setting. ABSTRACT: Background: Brain metastases (BM) are common in cancer patients and are associated with high morbidity and mortality. Surgery is an option, but the optimal selection of patients for surgery is challenging and controversial. Current prognostication tools are not ideal for preoperative prognostication. By using a reference population (derivation data set) and two external populations (validation data set) of patients who underwent surgery for BM, we aimed to create and validate a preoperative prognostic index. Methods: The derivation data set consists of 590 patients who underwent surgery for BM (2011–2018) at Oslo University Hospital. We identified variables associated with survival and created a preoperative prognostic index with four prognostic groups, which was validated on patients who underwent surgery for BM at Karolinska University Hospital and St. Olavs University Hospital during the same time period. To reduce over-fitting, we adjusted the index in accordance with our findings. Results: 438 patients were included in the validation data set. The preoperative prognostic index correctly divided patients into four true prognostic groups. The two prognostic groups with the poorest survival outcomes overlapped, and these were merged to create the adjusted preoperative prognostic index. Conclusion: We created a prognostic index for patients with BM that predicts overall survival preoperatively. This index might be valuable in supporting informed choice when considering surgery for BM.
format Online
Article
Text
id pubmed-10296417
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-102964172023-06-28 Preoperative Prognostic Index for Patients with Brain Metastases—A Population-Based Multi-Centre Study Winther, Rebecca Rootwelt Skovlund, Eva Andreassen, Joakim Stray Arvidsson, Lisa Halvardson, Jonathan Solheim, Ole Bartek, Jiri Kaasa, Stein Hjermstad, Marianne Jensen Vik-Mo, Einar Osland Cancers (Basel) Article SIMPLE SUMMARY: Metastases to the brain result in serious morbidity and mortality. Surgical resection is a treatment option; however, many patients die within a short time after surgery. It is therefore important to understand which patients may benefit from surgical resection. We have investigated prognostic factors for survival after surgery for brain metastases. We identified eight factors that significantly predicted survival in these patients and created a preoperative prognostic index to estimate survival and to guide clinical decision-making in evaluating surgery as a treatment for brain metastases. We tested our findings on patients who underwent the same treatment at two other large hospitals in Norway and Sweden, and our findings were valid. This is to our knowledge the first such index to support decision-making in this setting. ABSTRACT: Background: Brain metastases (BM) are common in cancer patients and are associated with high morbidity and mortality. Surgery is an option, but the optimal selection of patients for surgery is challenging and controversial. Current prognostication tools are not ideal for preoperative prognostication. By using a reference population (derivation data set) and two external populations (validation data set) of patients who underwent surgery for BM, we aimed to create and validate a preoperative prognostic index. Methods: The derivation data set consists of 590 patients who underwent surgery for BM (2011–2018) at Oslo University Hospital. We identified variables associated with survival and created a preoperative prognostic index with four prognostic groups, which was validated on patients who underwent surgery for BM at Karolinska University Hospital and St. Olavs University Hospital during the same time period. To reduce over-fitting, we adjusted the index in accordance with our findings. Results: 438 patients were included in the validation data set. The preoperative prognostic index correctly divided patients into four true prognostic groups. The two prognostic groups with the poorest survival outcomes overlapped, and these were merged to create the adjusted preoperative prognostic index. Conclusion: We created a prognostic index for patients with BM that predicts overall survival preoperatively. This index might be valuable in supporting informed choice when considering surgery for BM. MDPI 2023-06-13 /pmc/articles/PMC10296417/ /pubmed/37370784 http://dx.doi.org/10.3390/cancers15123174 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Winther, Rebecca Rootwelt
Skovlund, Eva
Andreassen, Joakim Stray
Arvidsson, Lisa
Halvardson, Jonathan
Solheim, Ole
Bartek, Jiri
Kaasa, Stein
Hjermstad, Marianne Jensen
Vik-Mo, Einar Osland
Preoperative Prognostic Index for Patients with Brain Metastases—A Population-Based Multi-Centre Study
title Preoperative Prognostic Index for Patients with Brain Metastases—A Population-Based Multi-Centre Study
title_full Preoperative Prognostic Index for Patients with Brain Metastases—A Population-Based Multi-Centre Study
title_fullStr Preoperative Prognostic Index for Patients with Brain Metastases—A Population-Based Multi-Centre Study
title_full_unstemmed Preoperative Prognostic Index for Patients with Brain Metastases—A Population-Based Multi-Centre Study
title_short Preoperative Prognostic Index for Patients with Brain Metastases—A Population-Based Multi-Centre Study
title_sort preoperative prognostic index for patients with brain metastases—a population-based multi-centre study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296417/
https://www.ncbi.nlm.nih.gov/pubmed/37370784
http://dx.doi.org/10.3390/cancers15123174
work_keys_str_mv AT wintherrebeccarootwelt preoperativeprognosticindexforpatientswithbrainmetastasesapopulationbasedmulticentrestudy
AT skovlundeva preoperativeprognosticindexforpatientswithbrainmetastasesapopulationbasedmulticentrestudy
AT andreassenjoakimstray preoperativeprognosticindexforpatientswithbrainmetastasesapopulationbasedmulticentrestudy
AT arvidssonlisa preoperativeprognosticindexforpatientswithbrainmetastasesapopulationbasedmulticentrestudy
AT halvardsonjonathan preoperativeprognosticindexforpatientswithbrainmetastasesapopulationbasedmulticentrestudy
AT solheimole preoperativeprognosticindexforpatientswithbrainmetastasesapopulationbasedmulticentrestudy
AT bartekjiri preoperativeprognosticindexforpatientswithbrainmetastasesapopulationbasedmulticentrestudy
AT kaasastein preoperativeprognosticindexforpatientswithbrainmetastasesapopulationbasedmulticentrestudy
AT hjermstadmariannejensen preoperativeprognosticindexforpatientswithbrainmetastasesapopulationbasedmulticentrestudy
AT vikmoeinarosland preoperativeprognosticindexforpatientswithbrainmetastasesapopulationbasedmulticentrestudy